Dr. Stanley Jones' Celltex stem cell therapy used in juvenile idiopathic arthritis case

Written by Laura Dyrda | April 26, 2015 | Print  |

Stanley Jones, MD, was featured in a recent Odessa American report discussing his company's stem cell therapy treatment for systematic juvenile idiopathic arthritis.


Dr. Jones co-founded Celltex Therapeutics with David Eller in 2011 for regenerative medicine through adult stem cells. The article features a young patient who underwent the stem cell therapy successfully relieve pain. The proprietary technology is designed to:


• Isolate adult autologous mesenchymal stem cells
• Multiply the cells
• Store the cells for later use in regenerative therapy


The therapy can be used for multiple vascular, autoimmune and degenerative diseases. Dr. Jones has been working to bring the technology to the United States for the past few years, and received the therapy in Asia for a spinal procedure.


More articles on spine surgery:
What dural closure methods are best for spine surgery? 5 things to know
Can a new peptide promote lumbar spinal fusion? 5 key notes
Dr. Patrick Hitchon becomes associate editor of Clinical Neurology and Neurosurgery

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months